Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T16:03:09.113Z.
Calculation as of: 2026-10-06T16:03:09.113Z.
Quote observation: 2026-10-06T15:42:42.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 28ff4bc206842fc4bf4b39bc6a519bf9e708a216f8b2554427075e3ddc5a9144
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$10.93M
EV/FCF Ratio
N/A
TTM Avg
5.79x
3Y Avg
5.79x
5Y Avg
5.79x
Market Cap
$10.06M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.01M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CytoMed Therapeutics Limited (GDTC) | $10.52M | N/A | N/A | N/A | N/A |
| Polyrizon Ltd. (PLRZ)vs › | $10.53M | N/A | N/A | N/A | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.55M | N/A | N/A | N/A | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $10.44M | N/A | N/A | N/A | N/A |
| Caring Brands, Inc. (CABR)vs › | $10.68M | N/A | N/A | N/A | N/A |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.93M | N/A | 5.79x | 5.79x | 5.79x |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | N/A | N/A | N/A | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $10.01M | N/A | N/A | N/A | N/A |
| BioVie Inc. (BIVI)vs › | $11.08M | N/A | N/A | N/A | N/A |
| Ainos, Inc. (AIMD)vs › | $9.79M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
